Ken Takanashi, Director at Wave Life Sciences Ltd. (WVE), sold 4,872 shares at $8.75 ($43K) on 2025-08-05, disclosed to the SEC on 2025-08-07.
Scheduled sale ($43k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| STSA | BUY | 2019-09-17 | $3.5M | — | Filing → |
| WVE | BUY | 2015-11-18 | $2.0M | — | Filing → |